Services
- Biorepository Solutions
- ULT Transport
- Unlicensed Medicines
- Patient Support Program
- Managed Access Program
- Post-Trial Access
- Early Access Program
- Clinical Trial Comparator Sourcing
- Clinical And Commercial Secondary Packaging And Labeling
- Clinical Trials Logistics
- Clinical Trial Material Storage and Distribution
- Global Logistics for Life Sciences
- Pharmaceutical Wholesale Distribution
- Specialty Medicines
- Regulatory Affairs Support
Early Access Program: Compassionate Solutions for Critical Needs!
Early Access Program (EAP) allows physicians and patients access to pre-approval, investigational drugs outside of the clinical trial setting or drugs still under development or pending market authorization. An EAP can also be called an Expanded Access Program or Compassionate Use Program. These programs are for patients suffering from a serious or life-threatening illness who have no viable treatment options available to them.
At Globyz Group, we are dedicated to providing hope through our Early Access Programs. We assist manufacturers in managing compassionate use programs, ensuring that patients in critical need have access to potentially life-saving treatments.
Comprehensive Management: Our EAP services include full management of compassionate use programs, encompassing pharmacovigilance and real-world data (RWD) collection.
Patient-Centric Approach: We prioritize the needs and safety of patients, working closely with healthcare providers to ensure seamless access to investigational drugs.
Regulatory Expertise: Our team navigates the complex regulatory landscape to facilitate access to treatments, ensuring compliance with all necessary guidelines.
Choose Globyz for reliable and compassionate Early Access Program solutions. Contact us today to learn more about how we can support your needs and provide critical treatments to those who need them most.